Comparison of gastric juice soluble triggering receptor expressed on myeloid cells and C-reactive protein for detection of Helicobacter pylori infection
Keywords:
sTREM-1, CRP, Helicobacter pylori, Gastric ulcer, Duodenal ulcer, GastritisAbstract
Background and aim: Triggering receptor expressed on myeloid cells (TREM-1) is a receptor on phagocytes that is triggered by infectious agents. The soluble form of it (sTREM-1) can be elevated in gastric juice by Helicobacter pylori (H. pylori) infection of gastric mucosa. The aim of this study was to compare the diagnostic values of sTREM-1 and C-reactive protein (CRP) for detection of H. pylori infection in gastric mucosa. Methods: In this diagnostic accuracy study on cases who underwent endoscopy from March 2015 to July 2016 in Shahid Beheshti Hospital, Kashan, Iran, gastric juice sTREM-1 and CRP concentrations were measured by enzyme-linked immunosorbent assays (ELISA) and their diagnostic values were compared to detect H. pylori infection. Gold standard test was histopathology. Data were entered into SPSS software version 16. Statistical analysis was made by Kolmogorov-Smirnov, Chi-square, Independent-samples t-test, Kruskal-Wallis, Mann-Whitney U, Pearson product-moment correlation, Receiver operating characteristic curve (ROC), Brier score, Nagelkerke R square and scaled reliability test. Results: Of a total of 160 cases, 81 (50.6%) were H. pylori-positive based on pathology. The level of sTREM-1 in H. pylori-positive patients was significantly higher than H. pylori-negative patients (p=0.000), but no significant difference between CRP concentrations was shown between groups (p=0.7). Sensitivity, specificity, positive likelihood ratio, negative likelihood ratio and accuracy of sTREM-1 were 82%, 75%, 3.3, 0.25, 78% and for CRP were 62%, 40%, 1.02, 0.98, 51% respectively for diagnosis of H. pylori infection. True positive and negative rates were 66 (81.5%) and 59 (74.7%) for sTREM-1 and 50 (61.7%) and 31 (39.2%) for CRP. The levels of sTREM-1 and CRP were not significantly different between endoscopic finding groups (p=0.97, p=0.2 respectively). Conclusion: Despite CRP, sTREM-1 was a relatively acceptable indicator of H. pylori infection of gastric mucosa.References
Padol S, Yuan Y, Thabane M, Padol IT, Hunt RH. The effect of CYP2C19 polymorphisms on H. pylori
eradication rate in dual and triple first-line PPI therapies: a meta-analysis. Am J Gastroenterol. 2006;
(7): 1467-75. doi: 10.1111/j.1572-0241.2006.00717.x. PMID: 16863547.
Calam J, Baron JH. ABC of the upper gastrointestinal tract: Pathophysiology of duodenal and gastric ulcer
and gastric cancer. BMJ. 2001; 323(7319): 980-2. PMID: 11679389, PMCID: PMC1121510.
Vakil N. Helicobacter pylori treatment: a practical approach. Am J Gastroenterol. 2006; 101(3): 497-9. doi:
1111/j.1572-0241.2006.00454.x. PMID: 16542285.
Eckmann L. Sensor molecules in intestinal innate immunity against bacterial infections. Curr Opin
Gastroenterol. 2006; 22(2): 95-101. doi: 10.1097/01.mog.0000208458.38772.2a. PMID: 16462163,
PMCID: PMC2695762.
Bouchon A, Dietrich J, Colonna M. Cutting edge: inflammatory responses can be triggered by TREM-1, a
novel receptor expressed on neutrophils and monocytes. J Immunol. 2000; 164(10): 4991-5. PMID:
Gibot S, Kolopp-Sarda MN, Bene MC, Bollaert PE, Lozniewski A, Mory F, et al. A soluble form of the
triggering receptor expressed on myeloid cells-1 modulates the inflammatory response in murine sepsis. J
Exp Med. 2004; 200(11): 1419-26. doi: 10.1084/jem.20040708. PMID: 15557347, PMCID: PMC2211948.
Koussoulas V, Tzivras M, Giamarellos-Bourboulis EJ, Demonakou M, Vassilliou S, Pelekanou A, et al.
Can soluble triggering receptor expressed on myeloid cells (sTREM-1) be considered an anti-inflammatory
mediator in the pathogenesis of peptic ulcer disease? Dig Dis Sci. 2007; 52(9): 2166-9. doi:
1007/s10620-006-9694-z. PMID: 17410457.
Koussoulas V, Vassiliou S, Demonakou M, Tassias G, Giamarellos-Bourboulis EJ, Mouktaroudi M, et al.
Soluble triggering receptor expressed on myeloid cells (sTREM-1): a new mediator involved in the
pathogenesis of peptic ulcer disease. Eur J Gastroenterol Hepatol. 2006; 18(4): 375-9. doi:
1097/00042737-200604000-00010. PMID: 16538108.
Koussoulas V, Vassiliou S, Spyridaki E, Demonakou M, Vaki I, Barbatzas C, et al. Evidence for the role of
gastric mucosa at the secretion of soluble triggering receptor expressed on myeloid cells (strem-1) in peptic
ulcer disease. World J Gastroenterol. 2007; 13(34): 4610-4. doi: 10.3748/wjg.v13.i34.4610. PMID:
, PMCID: PMC4611837.
Bopp C, Hofer S, Bouchon A, Zimmermann JB, Martin E, Weigand MA. Soluble TREM-1 is not suitable
for distinguishing between systemic inflammatory response syndrome and sepsis survivors and
nonsurvivors in the early stage of acute inflammation. Eur J Anaesthesiol. 2009; 26(6): 504-7. doi:
1097/EJA.0b013e328329afca. PMID: 19307971.
Gibot S, Le Renard PE, Bollaert PE, Kolopp-Sarda MN, Bene MC, Faure GC, et al. Surface triggering
receptor expressed on myeloid cells 1 expression patterns in septic shock. Intensive Care Med. 2005; 31(4):
-7. doi: 10.1007/s00134-005-2572-x. PMID: 15754199.
Phua J, Koay ES, Zhang D, Lee KH. How well do serum sTREM-1 measurements prognosticate in septic
shock? Anaesth Intensive Care. 2008; 36(5): 654-8. PMID: 18853582.
Rivera-Chavez FA, Minei JP. Soluble triggering receptor expressed on myeloid cells-1 is an early marker
of infection in the surgical intensive care unit. Surg Infect (Larchmt). 2009; 10(5): 435-9. doi:
1089/sur.2009.030. PMID: 19792836, PMCID: PMC2956524.
Cetinkaya M, Ozkan H, Koksal N, Celebi S, Hacimustafaoglu M. Comparison of serum amyloid A
concentrations with those of C-reactive protein and procalcitonin in diagnosis and follow-up of neonatal
sepsis in premature infants. J Perinatol. 2009; 29(3): 225-31. doi: 10.1038/jp.2008.207. PMID: 19078972.
Dillon MC, Opris DC, Kopanczyk R, Lickliter J, Cornwell HN, Bridges EG, et al. Detection of
homocysteine and C-reactive protein in the saliva of healthy adults: comparison with blood levels. Biomark
Insights. 2010; 5: 57-61. PMID: 20703322, PMCID: PMC2918353.
Ouellet-Morin I, Danese A, Williams B, Arseneault L. Validation of a high-sensitivity assay for C-reactive
protein in human saliva. Brain Behav Immun. 2011; 25(4): 640-6. doi: 10.1016/j.bbi.2010.12.020. PMID:
Lacaze-Masmonteil T, Rosychuk RJ, Robinson JL. Value of a single C-reactive protein measurement at 18
h of age. Arch Dis Child Fetal Neonatal Ed. 2014; 99(1): F76-9. doi: 10.1136/archdischild-2013-303984.
PMID: 24008814.
Ishida Y, Suzuki K, Taki K, Niwa T, Kurotsuchi S, Ando H, et al. Significant association between
Helicobacter pylori infection and serum C-reactive protein. Int J Med Sci. 2008; 5(4): 224-9. PMID:
, PMCID: PMC2500148.
Saribas S, Kocazeybek B, Aslan M, Altun S, Seyhun Y, Oner YA, et al. Do procalcitonin and C-reactive
protein levels have a place in the diagnosis and follow-up of Helicobacter pylori infections? J Med
Microbiol. 2004; 53(Pt 7): 639-44. doi: 10.1099/jmm.0.05398-0. PMID: 15184535.
Schenk M, Bouchon A, Birrer S, Colonna M, Mueller C. Macrophages expressing triggering receptor
expressed on myeloid cells-1 are underrepresented in the human intestine. J Immunol. 2005; 174(1): 517- 24. doi: 10.1097/00003246-200204000-0000.6. PMID: 15611278.
Koussoulas V, Giamarellos-Bourboulis EJ, Barbatzas C, Pimentel M. Serum sTREM-1 as a Surrogate
Marker of Treatment Outcome in Patients with Peptic Ulcer Disease. Dig Dis Sci. 2011; 56(12): 3590-5.
doi: 10.1007/s10620-011-1761-4. PMID: 21633832. .
Su L, Feng L, Song Q, Kang H, Zhang X, Liang Z, et al. Diagnostic value of dynamics serum sCD163,
sTREM-1, PCT, and CRP in differentiating sepsis, severity assessment, and prognostic prediction.
Mediators Inflamm. 2013; 2013: 969875. doi: 10.1155/2013/969875. PMID: 23935252, PMCID:
PMC3713373.
Lin CH, Hsieh SC, Keng LT, Lee HS, Chang HT, Liao WY, et al. Prospective Evaluation of Procalcitonin,
Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with
Autoimmune Diseases. PLoS One. 2016; 11(4): e0153938. doi: 10.1371/journal.pone.0153938. PMID:
, PMCID: PMC4838219.
Hofer N, Zacharias E, Muller W, Resch B. An update on the use of C-reactive protein in early-onset
neonatal sepsis: current insights and new tasks. Neonatology. 2012; 102(1): 25-36. doi:
1159/000336629. PMID: 22507868.
Claeys R, Vinken S, Spapen H, ver Elst K, Decochez K, Huyghens L, et al. Plasma procalcitonin and Creactive protein in acute septic shock: clinical and biological correlates. Crit Care Med. 2002; 30(4): 757- 62. PMID: 11940741.
Simon L, Gauvin F, Amre DK, Saint-Louis P, Lacroix J. Serum procalcitonin and C-reactive protein levels
as markers of bacterial infection: a systematic review and meta-analysis. Clin Infect Dis. 2004; 39(2): 206- 17. doi: 10.1086/421997. PMID: 15307030.
Miedema KG, de Bont ES, Elferink RF, van Vliet MJ, Nijhuis CS, Kamps WA, et al. The diagnostic value
of CRP, IL-8, PCT, and sTREM-1 in the detection of bacterial infections in pediatric oncology patients
with febrile neutropenia. Support Care Cancer. 2011; 19(10): 1593-600. doi: 10.1007/s00520-010-0987-6.
PMID: 20803037, PMCID: PMC3166608.
Iyengar A, Paulus JK, Gerlanc DJ, Maron JL. Detection and potential utility of C-reactive protein in saliva
of neonates. Front Pediatr. 2014; 2: 131. doi:10.3389/fped.2014.00131. PMID: 25485262, PMCID:
PMC4239436.
Stettin D, Waldmann A, Strohle A, Hahn A. Association between Helicobacter pylori-infection, C-reactive
protein and status of B vitamins. Adv Med Sci. 2008; 53(2): 205-13. doi: 10.2478/v10039-008-0050-8.
PMID: 19230307.
Jafarzadeh A, Hassanshahi GH, Nemati M. Serum levels of high-sensitivity C-reactive protein (hs-CRP)in
Helicobacter pylori-infected peptic ulcer patients and its association with bacterial CagA virulence factor.
Dig Dis Sci. 2009; 54(12): 2612-6. doi: 10.1007/s10620-008-0686-z. PMID: 19160050.
Published
Issue
Section
License
Copyright (c) 2020 KNOWLEDGE KINGDOM PUBLISHING
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
